Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy

ClinicalTrials.gov ID: NCT00006095

Public ClinicalTrials.gov record NCT00006095. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 3:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Trial of Irinotecan (NSC# 616348) Plus Vincristine in Children With Solid Tumors

Study identification

NCT ID
NCT00006095
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Children's Oncology Group
Network
Enrollment
20 participants

Conditions and interventions

Interventions

  • irinotecan hydrochloride Drug
  • vincristine sulfate Drug

Drug

Eligibility (public fields only)

Age range
1 Year to 21 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2000
Primary completion
Dec 31, 2004
Completion
Aug 31, 2005
Last update posted
Feb 20, 2014

2000 – 2005

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
18
Facility City State ZIP Site status
Cancer Center and Beckman Research Institute, City of Hope Duarte California 91010-3000
Children's Hospital Los Angeles Los Angeles California 90027-0700
Jonsson Comprehensive Cancer Center, UCLA Los Angeles California 90095-1781
Children's Hospital of Orange County Orange California 92868
UCSF Cancer Center and Cancer Research Institute San Francisco California 94143-0128
Children's National Medical Center Washington D.C. District of Columbia 20010-2970
Indiana University Cancer Center Indianapolis Indiana 46202-5289
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109-0752
University of Minnesota Cancer Center Minneapolis Minnesota 55455
Mayo Clinic Cancer Center Rochester Minnesota 55905
Children's Mercy Hospital Kansas City Missouri 64108
NYU School of Medicine's Kaplan Comprehensive Cancer Center New York New York 10016
Memorial Sloan-Kettering Cancer Center New York New York 10021
Mount Sinai School of Medicine New York New York 10029
Children's Hospital Medical Center - Cincinnati Cincinnati Ohio 45229-3039
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15213
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-6838
University of Texas - MD Anderson Cancer Center Houston Texas 77030-4009
Children's Hospital and Regional Medical Center - Seattle Seattle Washington 98105
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792-6164

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00006095, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 20, 2014 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00006095 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →